您当前位置：首页 > 国际期刊-Pharmacogenomics & Personalized Medicine期刊投稿发表详细信息

Pharmacogenomics & Personalized Medicine Q3

期刊收录：
SCIE
Scopus
DOAJ

基本信息

期刊ISSN：
1178-7066
期刊简拼：
PHARMACOGEN PERS MED
年发文章数：
93
E-ISSN：
Gold OA文章占比
98.46%
研究文章占比：
86.02%
是否OA：
Yes
Jcr分区：
Q3
中科院分区：
4区

出版信息

出版商：
Dove Medical Press
涉及研究方向：
Biochemistry, Genetics and Molecular Biology-Molecular Medicine
出版国家：
New Zealand
出版语言：
English
出版周期：
出版年份：

2023-2024最新影响因子:1.8
自引率:0.00%
五年影响因子:1.9
JCI期刊引文指标:0.56
h-index:暂无h-index数据
CiteScore:3.30

期刊关键词

3区 SCIE Scopus DOAJ 医学 4区 PHARMACOLOGY & PHARMACY 药学

期刊简介

Pharmacogenomics and Personalized Medicine is an international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.

In particular, emphasis will be given to:

Genomic and proteomic profiling
Genetics and drug metabolism
Targeted drug identification and discovery
Optimizing drug selection & dosage based on patient's genetic profile
Drug related morbidity & mortality intervention
Advanced disease screening and targeted therapeutic intervention
Genetic based vaccine development
Patient satisfaction and preference
Health economic evaluations
Practical and organizational issues in the development and implementation of personalized medicine programs.

《Pharmacogenomics & Personalized Medicine》期刊已被查看：次
期刊简写：PHARMACOGEN PERS MED

此期刊被最新的JCR期刊SCIE收录